Navigation Links
Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager Launches Educational Meetings for General Public on Umbilical Cord Blood Stem Cells
Date:5/8/2013

Miami, Florida (PRWEB) May 08, 2013

Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager, announced today her contribution in educating South Florida’s expecting parents to advance the awareness in the community. Expecting parents in Miami are encourage attend these meetings to learning more about this medical advancements in cord blood stem cells.

Ms. Reyes Muñoz joined GeneCell International as a Physician Relation's Manager, fluent in Spanish, with a science and pharmacology background. Reyes Muñoz has been interviewed by several Spanish networks including “Capsulas del Exito” and Preguntale a su Doctor, a weekly segment of GenTV (WGEN), in an effort to promote the awareness of cord blood preservation and its future potentials.

“What is most rewarding is to be able to apprise expecting parents and their families on the current and future treatments of these stem cells as well as explain the controversial differences about them," said Lisa Lorraine Reyes Muñoz.

Umbilical cord blood preservation is a process by which blood is collected from the umbilical cord of a newborn baby and is stored cryogenically in a specially-designated bank. According to the National Marrow Donor Program, cord blood contains cells that can be transfused to a patient to treat various diseases, including lymphoma and leukemia. The list of illnesses that can be treated with cord blood continues to grow.

“A person’s blood stem cell type is inherited, which means a patient is more likely to find a matched donor from within their own ethnic group,” said GeneCell’s Director of Operations, Jose Cirino. “More than half of cord blood donations and privately banked cord blood in the United States are from Caucasians while minorities remain underrepresented. By increasing the awareness of cord blood advantages among minorities, there is a potential for increased access to therapies for more people.”

Cord blood can be used to treat the child from whom the blood was collected as well as some first-degree relatives who are a close genetic match, such as family members. Cord blood banking is regulated by the U.S. Food & Drug Administration and each year more and more parents choose to save their children’s cord blood should the medical need arise.

GeneCell International specializes in the collection, transport, processing and cryogenic storage of adult stem cells from various sources including; umbilical cord blood, cord tissue segment, dental pulp (teeth) and adipose tissue (fat) that can later be used to treat a variety of diseases. The laboratory is also involved in scientific research and development with a range of stem cells from various adult tissues.

Alongside its commitment to educating the public on the benefits of cord blood preservation, GeneCell is committed to being on the forefront of stem cell research. GeneCell International is the only Cord Blood. Cord Tissue, Dental Pulp and Adipose Tissue Processing and Cryogenic Storage Laboratory to offer this cutting-edge, “regenerative medicine” technology in Miami, Florida.

GeneCell International, LLC is a trusted provider in the collection, processing and storage of adult stem cells from various sources which have the potential to treat a variety of diseases and disorders. Headquartered in Miami, Florida and with local offices in Central Florida, Colombia, Costa Rica, Dominican Republic, Honduras, India, Peru, Puerto Rico and Venezuela, GeneCell operates state of the art laboratories and storage facilities for thousands of clients. For more information and to learn more about cord blood banking, dental pulp or other GeneCell services, please visit our website at http://www.GeneCell.com.

Click the below links to visit other GeneCell informational pages:

# # #

Read the full story at http://www.prweb.com/releases/2013/5/prweb10711938.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GeneCell International Gives Back to the Community by Participating in Local Elementary School’s Career Day
2. Drogueria Americana, a Honduran Affiliate of GeneCell International, Presents to a Panel of More Than 100 Leading Dentist on Dental Pulp Stem Cells
3. Surveyed Physicians Indicate that Xtandi is Prescribed to Nearly One Quarter of Metastatic Castrate-Resistant Prostate Cancer Patients Who Have Failed to Respond to Prior Docetaxel Treatment
4. Dr. Ritchie Shoemaker Pleased to Announce Second Physician Achieves Shoemaker Protocol Certification for Treating Chronic Inflammatory Response Syndrome
5. New Obesity Education Program To Premiere At American College of Physicians (ACP) Annual Meeting
6. CHI Vice President Provides Testimony On Patient, Physician Notification of Biosimilar Substitution
7. Physicians for Peace Resource Mothers Program Receives Sweatshirt Blanket Donation
8. Physicians for Peace Receives Logo Embroidered Polo Shirt Donation
9. Texas Fertility Center Introduces Oncofertility Education Program for Physicians and Patients
10. Physicians Endoscopy and Colon Cancer Challenge Foundation Partner to Raise Colon Cancer Awareness
11. Physicians for Peace Resource Mothers Program Receives Fleece Blanket Donation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... PHOENIX and SAN DIEGO ... (OTCQB:CELZ) announced the appointment of Santosh Kesari , ... Board. Dr. Kesari will leverage his experience in neurology and ... its adult stem cell for treatment of stroke. The AmnioStem ... amniotic fluid, which has previously shown therapeutic activity in ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... on discovery and development of precision treatments for neurodegenerative diseases, today announced ... disease (AD) inhibited the direct neurotoxic effect of prion-like forms of Amyloid ...
(Date:12/5/2016)... DUBLIN , Dec 5, 2016 ... report "Biomarkers - Technologies, Markets and Companies" to their ... , , ... biomarkers and their discovery using various -omics technologies such as proteomics ... biomarkers and new tests are also based on biomarker. ...
(Date:12/5/2016)... SAN DIEGO , Dec. 5, 2016 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and other chronic ... is joining the company as Chief Financial Officer ... Renova Therapeutics with 20 years of experience in ... closely held biotech and software companies. Most recently, ...
Breaking Biology Technology:
(Date:12/6/2016)... N.C. , Dec. 6, 2016 Valencell ... announced today it has seen a third consecutive year ... biometric sensor technology in 2016 with a 360 percent ... last year. This increase was driven by sales of ... as robust interest in its technology for hearables for ...
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
(Date:11/30/2016)... CHICAGO , Nov. 30, 2016  higi ... a new partnership initiative targeting national brands, industry ... and reward their respective audiences for taking steps ... Since its inception in 2012, higi has built ... US, impacting over 38 million people who have ...
Breaking Biology News(10 mins):